Literature DB >> 6208137

Serological and biochemical analyses of monoclonal antibodies to human melanoma-associated antigens.

J R Harper, T F Bumol, R A Reisfeld.   

Abstract

Monoclonal antibodies submitted and exchanged by participating laboratories were analyzed serologically and biochemically in accordance with the goals and aims of the Workshop on Monoclonal Antibodies to Melanoma. Serological evaluation of the workshop panel revealed that when a variety of tumor and normal cell lines were tested by enzyme-linked immunoassay, a majority of antibodies reacted preferentially with melanoma cells. Indirect immunoprecipitation analysis of those antibodies that bound staphylococcal protein A provided molecular weight estimates for some antigens and additional information that suggested possible commonalities among antigens recognized by antibodies 9.2.27, 225.28S and 763.24TS. Competitive binding analyses demonstrated that antibodies 225.288 and 763.24TS bound separate and distinct epitopes from that recognized by antibody 9.2.27 on the core glycoprotein of melanoma-associated chondroitin sulfate proteoglycans. Immunoperoxidase staining of fresh frozen melanoma tissue with antibody 9.2.27 revealed a limited tissue distribution and preferential association with the cell surface of human melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6208137     DOI: 10.1089/hyb.1.1982.1.423

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  5 in total

1.  Bispecific-monoclonal-antibody-directed lysis of ovarian carcinoma cells by activated human T lymphocytes.

Authors:  S A Möller; R A Reisfeld
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells.

Authors:  D A Cheresh; J R Harper; G Schulz; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Monoclonal antibodies that prevent adhesion of B 16 melanoma cells and reduce metastases in mice: crossreaction with human tumor cells.

Authors:  H P Vollmers; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

4.  Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.

Authors:  G Pluschke; M Vanek; A Evans; T Dittmar; P Schmid; P Itin; E J Filardo; R A Reisfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 5.  Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types.

Authors:  Kristina M Ilieva; Anthony Cheung; Silvia Mele; Giulia Chiaruttini; Silvia Crescioli; Merope Griffin; Mano Nakamura; James F Spicer; Sophia Tsoka; Katie E Lacy; Andrew N J Tutt; Sophia N Karagiannis
Journal:  Front Immunol       Date:  2018-01-10       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.